<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03968666</url>
  </required_header>
  <id_info>
    <org_study_id>1396793</org_study_id>
    <nct_id>NCT03968666</nct_id>
  </id_info>
  <brief_title>Compliance With Enhanced Recovery After Surgery Protocol (ERAS) in Surgical Patients</brief_title>
  <official_title>Evaluation of Compliance With Enhanced Recovery After Surgery (ERAS) Protocol in Benign Gynecological Surgical Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Augusta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Augusta University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The concept of &quot;enhanced recovery&quot; was introduced by European anesthesiologists and surgeons&#xD;
      who challenged traditional clinical practices involved in peri-operative care in 1990s. The&#xD;
      goal of enhanced recovery programs (ERP) is to maintain normal physiology thereby decreasing&#xD;
      complications. It focuses on peri-operative optimization of patient care. It was originally&#xD;
      created for open colorectal surgeries but now has shown benefit in various surgical&#xD;
      specialities including thoracic surgery, vascular surgery, hepatobiliary as well as&#xD;
      gynecological surgery.&#xD;
&#xD;
      The successful implementation of structured ERAS program requires an ERAS protocol, audit&#xD;
      system and a multidisciplinary team. The investigators will evaluate the effect of compliance&#xD;
      with the protocol and outcomes such as length of stay, readmissions, morbidity and mortality.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After approval by the Institutional Review Board, the investigators plan to retrospectively&#xD;
      study gynecological patients who underwent ERAS protocol at Augusta University Medical Center&#xD;
      between January 2017 and February 2019.&#xD;
&#xD;
      This is a retrospective observational study to evaluate the outcomes of patients who had ERAS&#xD;
      protocol during their surgery.&#xD;
&#xD;
      Demographic and outcome variables will be obtained from the institutional health&#xD;
      documentation system. The investigators will collect demographic variables (age, ASA status),&#xD;
      morphometric measurements (body mass index), time from enrollment to ERAS protocol,&#xD;
      hospitalization length of stay, and readmission rate. The investigators will also record the&#xD;
      documentation of the ERAS protocol interventions against the ERAS protocol approved by the&#xD;
      institution. The investigators will assess the effect of the degree of compliance on outcome&#xD;
      variables.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">October 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Length of stay</measure>
    <time_frame>2 weeks</time_frame>
    <description>Days from surgery to discharge from the hospital</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Readmission</measure>
    <time_frame>2 weeks</time_frame>
    <description>Admission to hospital after discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>2 weeks</time_frame>
    <description>Number of fatalities after surgery</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Surgery</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Gynecological surgery with ERAS protocol</arm_group_label>
    <description>Patients scheduled for benign gynecological surgery under ERAS protocol</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for benign gynecologic surgery who underwent ERAS protocol&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All elective benign gynecological surgical patients enrolled under ERAS protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of oncologic pathologies&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Gynecological surgery</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Efrain Riveros Perez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Augusta University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Efrain Riveros Perez, MD</last_name>
    <phone>3304074681</phone>
    <email>eriverosperez@augusta.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Augusta University</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steffen Meiler, MD</last_name>
      <phone>706-721-3671</phone>
      <email>smeiler@augusta.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>May 28, 2019</study_first_submitted>
  <study_first_submitted_qc>May 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2019</study_first_posted>
  <last_update_submitted>July 21, 2021</last_update_submitted>
  <last_update_submitted_qc>July 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Augusta University</investigator_affiliation>
    <investigator_full_name>Efrain Riveros Perez, MD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

